|
In this episode we are joined by Kevin Conroy, Chairman and Chief Executive Officer at Exact Sciences, to discuss cancer innovation, including the role of early detection in the future of healthcare, what screening, prevention, and detection could look like in the future, why diagnostic tests are important in fighting healthcare disparities, and a lot more.
Cologuard is intended to screen adults 45 and older at average risk for colorectal cancer. Rx only.
Please see important risk information at Cologuard.com and http://www.exactsciencespo.com/.
This episode is sponsored by Exact Sciences.
|
.png)
More
Religion & Spirituality
Education
Arts and Design
Health
Fashion & Beauty
Government & Organizations
Kids & family
Music
News & Politics
Science & Medicine
Society & Culture
Sports & Recreation
TV & Film
Technology
Philosophy
Storytelling
Horror and Paranomal
True Crime
Leisure
Travel
Fiction
Crypto
Marketing
History
Comedy
Arts
Games & Hobbies
Business
Motivation